• ANI Pharmaceuticals director Patrick D. Walsh reported sales totaling 13,973 common shares in transactions dated May 11 and May 13.
• Sales were priced at USD 80.75 and USD 80.63.
• Directly held stake fell to 38,432 common shares following latest sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001720568-26-000005), on May 13, 2026, and is solely responsible for the information contained therein.